Enzymatically modified isoquercitrin (EMIQ) is a highly bioavailable form of quercetin – a flavonoid that exerts significant anti-allergy effects. The limiting factor in quercetin’s clinical efficacy appears to be its poor bioavailability, so EMIQ by Natural Factors offers consumers a more efficacious product.
Enzymatically modified isoquercitrin (EMIQ) is a highly bioavailable form of quercetin – a flavonoid that exerts significant anti-allergy effects. EMIQ is manufactured through natural enzymatic process that attaches glucose chains (glycosides) to the quercetin molecule. The result of this modification is that the quercetin is provided in a water-soluble form thereby greatly enhancing its bioavailability. In the digestive process the glycoside portion is cleaved, liberating the quercetin, and as a result EMIQ greatly increases quercetin levels in the blood compared to the ingestion of quercetin or its related compound rutin. Blood levels of quercetin are more than 40 times greater with EMIQ compared to an equal amount of quercetin.
EMIQ has been found to be safe in many toxicity studies and has been self-affirmed as Generally Recognized as Safe (GRAS) for use in specific foods in the US and as an antioxidant. Natural Factors Bioactive Quercetin EMIQ contains no GMOs, artificial colours, preservatives or sweeteners, fish, shellfish or animal products, and is suitable for vegetarians/vegans.
EMIQ or Enzymatically Modified Isoquercitrin is prepared by using a natural enzyme process that attaches polysaccharides to convert quercetin, which has poor bioavailability, into a soluble form (Alpha-Glycosyl Isoquercitrin). EMIQ provides the benefits of quercetin with high absorption and superior bioavailability. According to pharmacokinetic data, the absorption of EMIQ is up to 40 times greater and 15 times greater than that of quercetin and reaches peak levels in the bloodstream in just 15 minutes. An antioxidant for the maintenance of good health.